Sr Director, Global Supply Chain Capabilities Accelerator at Bristol-Myers Squibb

Boudry, Neuchatel, Switzerland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, Supply ChainIndustries

Requirements

Visionary digital leader capable of bridging business and technology
Experience architecting and owning end-to-end digital transformation strategies for supply chain
Expertise in driving adoption of cutting-edge technologies (AI/ML, IoT, advanced analytics, automation)
Ability to act as strategic translator and thought leader between business operations and technology teams
Skills in user-centric design, change management, and driving adoption with KPIs
Proficiency in data governance, security, compliance, predictive analytics, and real-time insights
Capability to mentor and develop high-performing, digitally savvy teams
Strong stakeholder engagement and cross-functional collaboration skills, especially with GPS and IT/BI&T

Responsibilities

Lead cross-functional projects for digital process redesign and supply chain capability building
Serve as strategic translator between business operations and technology teams, facilitating communication and ecosystem design
Design, deliver, own, and evolve the global GSC digital roadmap, aligning with enterprise ambitions and infusing AI across supply chain modalities
Identify and drive transformational improvements leveraging emerging technologies in partnership with BI&T
Represent GSC digital strategy internally and externally, influencing stakeholders and serving as primary contact for GPS and BI&T
Champion user-centric design and deployment of digital solutions, ensuring intuitiveness and tailoring to end-user needs
Lead change management efforts to drive adoption and sustainment of digital capabilities, monitoring KPIs
Simplify processes for digital readiness and identify opportunities for digital innovation
Drive requirements and adoption of foundational/advanced data capabilities for predictive analytics, real-time insights, and automation
Ensure robust data governance, security, and compliance across digital initiatives
Drive a culture of digital innovation and continuous improvement, championing advanced technologies and agile methodologies
Mentor and develop a high-performing team, fostering experimentation and rapid prototyping
Engage stakeholders for cohesive execution of digital initiatives and cross-functional collaboration
Partner with B&IT and GPS to evaluate, select, and implement scalable digital solutions ensuring interoperability

Skills

Digital Transformation

Supply Chain Management

Data-Driven Decision-Making

Process Automation

Digital Roadmap

Cross-Functional Leadership

Strategic Translation

Emerging Technologies

Business Technology Integration

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free